United States· US:0113-0443_f4f565d3-dd7e-4ae4-9fb0-8a7819d7d83c
Good Sense Nasal Allergy
A medicinal product containing triamcinolone acetonide, registered in United States by L. Perrigo Company.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Triamcinolone acetonide
- Manufacturer
- L. Perrigo Company
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc1101130443011 BOTTLE, SPRAY in 1 CARTON (0113-0443-01) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Triamcinolone acetonide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaAPO-TRIAMCINOLONE AQAPOTEX INC
- GermanyKortikoidRatiopharm Gmbh
- United KingdomAdcortyl in Orabase 0.1% oromucosal pasteBristol-Myers Squibb Pharmaceuticals Ltd
- NetherlandsCremor triamcinolonacetonide 0,1% Mylan, creme 1 mg/gMylan B.V.
- NorwayKenacort RetardBristol-Myers Squibb
- BelgiumAlbicort 10Sanofi Belgium
- FinlandAftabMeda Oy
- Japanトリアムシノロンアセトニド
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Volon, Volon A
- Belgium · Delphi, Kenacort-A
- Cyprus · Triacort
- Czechia · Triamcinolon Léčiva
- Germany · Nasacort, Rhinisan
- Denmark · Kenalog, Triamcinolone Acetonide Medipha
- Estonia · Kenalog
- Spain · Nasacort
- Finland · Nasacort, Triamcinolone Medipha
- France · Kenacort Retard, Nasacort
- United Kingdom (Northern Ireland) · Nasacort
- Greece · Jiven, Nasacort
- Croatia · Kenalog
- Hungary · Ftorocort, Kenalog
- Ireland · Nasacort, Nasacort Allergy
- Iceland · Kenacort-T, Nasacort
- Italy · Kenacort, Nasacort
- Lithuania · Ftorocort, Kenalog
- Luxembourg · Delphi, Kenacort-A
- Latvia · Ftorocort, Kenalog
- Malta · Nasacort, Nasacort Allergy
- Netherlands · Cremor Triamcinolonacetonide, Kenacort-A 10
- Norway · Kenacort-T, Nasacort
- Poland · Polcortolon
- Portugal · Nasacort, Telfast Spray Nasal
- Sweden · Kenacort-T, Nasacort
- Slovenia · Kenalog
- Slovakia · Triamcinolon Crm Léčiva, Triamcinolon Ung Léčiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/314480f9-f03f-49df-b306-b72c3d4022a9 GET /v1/drugs/314480f9-f03f-49df-b306-b72c3d4022a9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "NASAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 5
},
"productid": "0113-0443_f4f565d3-dd7e-4ae4-9fb0-8a7819d7d83c",
"productndc": "0113-0443",
"dosage_form": "SPRAY, METERED",
"dea_schedule": null,
"product_type": "HUMAN OTC DRUG",
"substance_name": "TRIAMCINOLONE ACETONIDE",
"proprietary_name": "Good Sense Nasal Allergy",
"active_ingred_unit": "ug/1",
"application_number": "ANDA078104",
"marketing_category": "ANDA",
"nonproprietary_name": "Triamcinolone acetonide",
"start_marketing_date": "20170209",
"active_numerator_strength": "55"
}See everything about triamcinolone acetonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.